# A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid

> **NCT04811404** · PHASE4 · WITHDRAWN · sponsor: **New York State Psychiatric Institute**

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Ethyl Eicosapentaenoic Acid

## Key facts

- **NCT ID:** NCT04811404
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03-19
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Reassessment of rationale for study
- **Last updated:** 2022-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04811404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04811404, "A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04811404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*